Inhibition of TFF3 Enhances Sensitivity—and Overcomes Acquired Resistance—to Doxorubicin in Estrogen Receptor-Positive Mammary Carcinoma
出版年份 2019 全文链接
标题
Inhibition of TFF3 Enhances Sensitivity—and Overcomes Acquired Resistance—to Doxorubicin in Estrogen Receptor-Positive Mammary Carcinoma
作者
关键词
-
出版物
Cancers
Volume 11, Issue 10, Pages 1528
出版商
MDPI AG
发表日期
2019-10-11
DOI
10.3390/cancers11101528
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Trefoil factors peptide-3 is associated with residual invasive breast carcinoma following neoadjuvant chemotherapy
- (2019) Suhail Al-Salam et al. BMC CANCER
- Effect of resveratrol on doxorubicin resistance in breast neoplasm cells by modulating PI3K/Akt signaling pathway
- (2018) Ju-Min Chen et al. IUBMB LIFE
- Maximising the potential of AKT inhibitors as anti-cancer treatments
- (2017) Jessica S. Brown et al. PHARMACOLOGY & THERAPEUTICS
- Release of HER2 repression of trefoil factor 3 (TFF3) expression mediates trastuzumab resistance in HER2+/ER+ mammary carcinoma
- (2017) Qing-Yun Chong et al. Oncotarget
- Trefoil factor 3 mediation of oncogenicity and chemoresistance in hepatocellular carcinoma is AKT-BCL-2 dependent
- (2017) Ming-Liang You et al. Oncotarget
- Serum TFF1 and TFF3 but not TFF2 are higher in women with breast cancer than in women without breast cancer
- (2017) Yuko Ishibashi et al. Scientific Reports
- Phase I Study of an AKT Inhibitor (MK-2206) Combined with Lapatinib in Adult Solid Tumors Followed by Dose Expansion in Advanced HER2+ Breast Cancer
- (2016) K. B. Wisinski et al. CLINICAL CANCER RESEARCH
- Is There a Future for AKT Inhibitors in the Treatment of Cancer?
- (2016) V. M. Jansen et al. CLINICAL CANCER RESEARCH
- PI3K Inhibitor Combined With Chemotherapy Can Enhance the Apoptosis of Neuroblastoma Cells In Vitro and In Vivo
- (2016) Xianjie Geng et al. TECHNOLOGY IN CANCER RESEARCH & TREATMENT
- ITF promotes migration of intestinal epithelial cells through crosstalk between the ERK and JAK/STAT3 pathways
- (2016) Juan Le et al. Scientific Reports
- Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer
- (2015) Stéphane Terry et al. CANCER
- Trefoil factor 3 (TFF3) enhances the oncogenic characteristics of prostate carcinoma cells and reduces sensitivity to ionising radiation
- (2015) Omesha Perera et al. CANCER LETTERS
- Trefoil Factor-3 (TFF3) Stimulates De Novo Angiogenesis in Mammary Carcinoma both Directly and Indirectly via IL-8/CXCR2
- (2015) Wai-Hoe Lau et al. PLoS One
- Trefoil Factor 3 Is Oncogenic and Mediates Anti-Estrogen Resistance in Human Mammary Carcinoma
- (2015) Nagarajan Kannan et al. NEOPLASIA
- Three-Dimensional Cell Culture Systems and Their Applications in Drug Discovery and Cell-Based Biosensors
- (2014) Rasheena Edmondson et al. ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES
- Intestinal trefoil factor activates the PI3K/Akt signaling pathway to protect gastric mucosal epithelium from damage
- (2014) ZHAORUI SUN et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- PI3K and cancer: lessons, challenges and opportunities
- (2014) David A. Fruman et al. NATURE REVIEWS DRUG DISCOVERY
- Trefoil factors in inflammatory bowel disease
- (2014) Luise Aamann WORLD JOURNAL OF GASTROENTEROLOGY
- Trefoil factor 3 peptide regulates migration via a Twist-dependent pathway in gastric cell
- (2013) Qianqian Zheng et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The protective effect of trefoil factor 3 on the intestinal tight junction barrier is mediated by toll-like receptor 2 via a PI3K/Akt dependent mechanism
- (2013) Nan Lin et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Trefoil factor family 3 (TFF3) expression and its interaction with estrogen receptor (ER) in endometrial adenocarcinoma
- (2013) Paulette Mhawech-Fauceglia et al. GYNECOLOGIC ONCOLOGY
- PI3K Inhibition Enhances Doxorubicin-Induced Apoptosis in Sarcoma Cells
- (2013) Diana Marklein et al. PLoS One
- Differential expression of gastric MUC5AC in colonic epithelial cells: TFF3-wired IL1 /Akt crosstalk-induced mucosal immune response against Shigella dysenteriae infection
- (2012) S. B. Raja et al. JOURNAL OF CELL SCIENCE
- Inhibition of doxorubicin-induced HER3-PI3K-AKT signalling enhances apoptosis of ovarian cancer cells
- (2012) Martin Bezler et al. Molecular Oncology
- Increased trefoil factor 3 levels in the serum of patients with three major histological subtypes of lung cancer
- (2012) YIQING QU et al. ONCOLOGY REPORTS
- AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity
- (2011) Sarat Chandarlapaty et al. CANCER CELL
- Mechanism of Cell Adaptation
- (2011) Valentina Fodale et al. CANCER JOURNAL
- Involvement of Akt and mTOR in chemotherapeutic- and hormonal-based drug resistance and response to radiation in breast cancer cells
- (2011) Linda S. Steelman et al. CELL CYCLE
- Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
- (2010) T.-C. Chou CANCER RESEARCH
- Doxorubicin: The Good, the Bad and the Ugly Effect
- (2009) Cristina Carvalho et al. CURRENT MEDICINAL CHEMISTRY
- Signal transduction and gene transcription induced by TFF3 in oral keratinocytes
- (2009) Trond Storesund et al. EUROPEAN JOURNAL OF ORAL SCIENCES
- Are trefoil factors oncogenic?
- (2007) Jo K. Perry et al. TRENDS IN ENDOCRINOLOGY AND METABOLISM
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started